Suppr超能文献

埃索美拉唑对大鼠硬膜外纤维化的抗纤维化作用。

Esomeprazole's Antifibrotic Effects on Rats With Epidural Fibrosis.

作者信息

Borekci Ali, Kuru Bektasoglu Pinar, Somay Adnan, Hazneci Jülide, Gürer Bora

机构信息

University of Health Sciences, Fatih Sultan Mehmet Education and Research Hospital, Department of Neurosurgery, Istanbul, Turkiye.

University of Health Sciences, Fatih Sultan Mehmet Education and Research Hospital, Department of Pathology, Istanbul, Turkiye.

出版信息

Global Spine J. 2025 Jun;15(5):2611-2616. doi: 10.1177/21925682241306045. Epub 2024 Dec 2.

Abstract

Study DesignRat subjects were randomly assigned to control, local, and systemic esomeprazole groups (n = 4-6 per group).ObjectiveExcessive scar formation after laminectomy can cause nerve entrapment and postoperative pain and discomfort. A rat laminectomy model determined whether topical application and systemic administration of esomeprazole can prevent epidural fibrosis.MethodsLaminectomy alone was performed in the control group. Topical esomeprazole was introduced to the laminectomy area in the local esomeprazole group. Intraperitoneal esomeprazole was introduced in the systemic esomeprazole group following laminectomy. Macroscopic and histopathologic examinations were performed four weeks after laminectomy.ResultsIn the systemic esomeprazole group, the macroscopic epidural fibrosis score was less than the control group ( < 0.001). Microscopic epidural fibrosis score and fibroblast cell density classification scores in local and systemic esomeprazole groups did not significantly differ. Fibrosis thickness was significantly lower in the local and systemic esomeprazole groups compared to the control group ( < 0.01, < 0.001, respectively).ConclusionsEsomeprazole reduced the formation of epidural fibrosis in the rat laminectomy model.

摘要

研究设计

将大鼠随机分为对照组、局部应用埃索美拉唑组和全身应用埃索美拉唑组(每组n = 4 - 6只)。

目的

椎板切除术后过度的瘢痕形成可导致神经受压及术后疼痛和不适。大鼠椎板切除模型用于确定局部应用和全身应用埃索美拉唑是否能预防硬膜外纤维化。

方法

对照组仅行椎板切除术。局部应用埃索美拉唑组将埃索美拉唑应用于椎板切除区域。全身应用埃索美拉唑组在椎板切除术后腹腔内注射埃索美拉唑。椎板切除术后四周进行宏观和组织病理学检查。

结果

全身应用埃索美拉唑组的宏观硬膜外纤维化评分低于对照组(< 0.001)。局部和全身应用埃索美拉唑组的微观硬膜外纤维化评分和成纤维细胞密度分类评分无显著差异。与对照组相比,局部和全身应用埃索美拉唑组的纤维化厚度显著更低(分别为< 0.01,< 0.001)。

结论

在大鼠椎板切除模型中,埃索美拉唑减少了硬膜外纤维化的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e6/12127695/5410acc6092e/10.1177_21925682241306045-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验